1. Home
  2. OGEN vs XXII Comparison

OGEN vs XXII Comparison

Compare OGEN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.60

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$2.22

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGEN
XXII
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.3M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
OGEN
XXII
Price
$0.60
$2.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
242.8K
29.4K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.96
EPS
N/A
N/A
Revenue
N/A
$25,832,530.00
Revenue This Year
N/A
$370.28
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.67
52 Week High
$9.16
$11.37

Technical Indicators

Market Signals
Indicator
OGEN
XXII
Relative Strength Index (RSI) 39.05 25.79
Support Level N/A $2.18
Resistance Level $1.02 $2.67
Average True Range (ATR) 0.06 0.26
MACD -0.02 -0.10
Stochastic Oscillator 29.10 13.59

Price Performance

Historical Comparison
OGEN
XXII

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: